← SynDRA
SELEGILINE
SynDRA canonical compound SYN0002820 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | MAOB |
|---|
| Mechanism of action | Monoamine oxidase inhibitor |
|---|
| Indication | Parkinson's Disease |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- MAOB
- MAOA
- ADRA2A
- ADRA2B
- CYP2B6
- CYP2C19
- Maoa
- Maob
- SNCA
- TACR1
Mechanisms of action (all sources)
- Monoamine oxidase inhibitor
- MAOB INHIBITOR
- Monoamine oxidase B inhibitor
- TACR1 ANTAGONIST
- MAOB MODULATOR
Drug classes
- Monoamine Oxidase Inhibitors
- Anti-Dyskinesia Agents
- Antidepressive Agents
- Antiparkinson Agents
- Central Nervous System Agents
- Enzyme Inhibitors
- Neuroprotective Agents
- Protective Agents
- Psychotropic Drugs
- Monoamine Oxidase Inhibitor
- Monoamine Oxidase-B Inhibitors
- Monoamine Oxidase Type B Inhibitor
ATC classes
- N04B · DOPAMINERGIC AGENTS
Cross-references
Synonyms
- (-)-deprenil
- (-)-deprenyl
- (-)-selegiline
- (r)-(-)-deprenyl
- (r)-selegiline
- anipryl
- l-deprenyl
- selegina
- selgene
- zelapar
- selegiline hydrochloride
- selegiline HCl
- Selegilina
- L-selegiline
- Emsam
- Selegiline Hydrochloride
- Selegiline Hcl
- (-)-Deprenyl hydrochloride
- l-Deprenyl hydrochloride
- Jumex hydrochloride
- Eldepryl hydrochloride
- (-)-Deprenil hydrochloride
- (R)-N-Methyl-N-(1-phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride
- (-)-E-250 hydrochloride
- UNII-6W731X367Q
- HSDB 7183
- R-(-)-Deprenyl (hydrochloride)
- FPF1100
- (-)-Phenylisopropylmethylpropynylamine
- 6W731X367Q
- (-)-(R)-N,alpha-Dimethyl-N-2-propynylphenethylamine hydrochloride
- Zydis selegiline
- L-Deprenalin
- Selegilinum
- Carbex
- Selegilinum [INN-Latin]
- Selegilina [INN-Spanish]
- UNII-2K1V7GP655
Reported adverse events
- Pain
- Hallucination
- Headache
- Nausea
- Dry mouth
- Dizziness
- Dyskinesia
- Insomnia
- Anxiety
- Lethargy
- Malaise
- Palpitations
Look up SELEGILINE in the interactive SynDRA portal →